NetworkNewsBreaks

FridayApr 12, 2024 1:24 pm

NetworkNewsBreaks – Yahoo! Finance Publishes Article on Big Tech-Led Rebound in US Stocks

Yahoo Finance published an article that discussed the U.S. stock surge on Thursday as big tech stocks led a rebound from a sell-off fueled by Wednesday’s surprise uptick in consumer prices. The article noted that members of the “Magnificent 7” tech stocks, a group that includes Apple Inc. (NASDAQ: AAPL), Nvidia Corp. (NASDAQ: NVDA), Amazon.com Inc. (NASDAQ: AMZN), Alphabet Inc. (NASDAQ: GOOGL, GOOG), Microsoft Corp. (NASDAQ: MSFT), Meta Platforms Inc. (NASDAQ: META), and Tesla Inc. (NASDAQ: TSLA), helped lead the rally. “Apple and Nvidia were both up more than 4%, while Amazon gained more than 1.5% to hit its first…

Continue Reading

FridayApr 12, 2024 12:52 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Closes on Public Offering Valued at Estimated $5.2M

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has closed on its previously announced public offering. The offering was comprised of up to 2,234,043 shares of Class A LGVN common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 2,234,043 shares of Class A common stock, both offered at $2.35 per share and associated warrant. The announcement noted that the warrants are exercisable upon issuance for up to five years. The public offering resulted in gross…

Continue Reading

FridayApr 12, 2024 11:44 am

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare

Sigyn Therapeutics (OTCQB: SIGY), a medical technology that creates medical solutions to treat life-threatening conditions, is developing a portfolio of technologies, including Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM) and ImmunePrep(TM), which have each been designed to overcome a current limitation in healthcare. “As it relates to pathogen-associated disorders, the company has advanced Sigyn Therapy(TM) from concept through product development and subsequently completed five invitro blood purification studies, which validated the ability of Sigyn Therapy(TM) to extract 12 different therapeutic targets from human blood plasma. As a result of these study outcomes, Sigyn Therapy is a candidate to treat a wide range of…

Continue Reading

FridayApr 12, 2024 11:37 am

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Announces ‘Milestone Achievement’ on Journey to Developing PAX-101

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has completed the execution of three pivotal registration/validation batches of PAX-101, which is an IV formulation of suramin. According to the announcement, this is an important milestone achievement as the company works toward enabling a New Drug Application (“NDA”) submission to the U.S. Food and Drug Administration (“FDA”). Currently, the company anticipates submitting the NDA in Q4 2024; this will mark another key milestone as the company works toward the potential commercial availability in the United States of the first and only form of suramin for the…

Continue Reading

ThursdayApr 11, 2024 3:50 pm

NetworkNewsBreaks – Riley Exploration Permian Inc. (NYSE American: REPX) Closes on $65.2M Public Offering

Riley Exploration Permian (NYSE American: REPX), a growth-oriented, independent oil and natural-gas company, has released the pricing of its previously announced underwritten public offering. The offering is comprised of 2,100,000 shares of common stock at $27 per share; the offering includes 700,000 shares offered by the company and 1,400,000 shares being offered by REPX stockholders. In addition, Riley Permian granted the underwriters a 30-day option to purchase up to 315,000 additional shares of common stock at the public offering price, minus underwriting discounts and commissions. The option was fully exercised. According to the announcement, gross proceeds from the offering, which…

Continue Reading

ThursdayApr 11, 2024 3:47 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Looking to Advance Discussions for Accelerated Approval, New NDA for CNM-Au8(R) in 2024

Clene (NASDAQ: CLNN), alongside its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. These include amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “Clene’s lead candidate, CNM-Au8(R), is a gold nanocrystal suspension that has emerged as a promising candidate for the treatment of both ALS and MS… Despite the FDA’s decision in late 2023 against allowing Clene to move forward with an accelerated approval pathway based on initial biomarker data, Clene is diligently preparing supplemental data to provide additional supportive biomarker, survival and mechanistic…

Continue Reading

ThursdayApr 11, 2024 3:34 pm

NetworkNewsBreaks – Boston Hemp Inc Recognized as Nation’s Largest Supplier of Premium, Indoor THCa Flower and Extracts

Boston Hemp, a leading player in the hemp industry, today announced its achievement of being recognized as the nation’s largest supplier of exotic indoor THCa flower and extracts. With a commitment to quality and innovation, Boston Hemp has rapidly emerged as a key player in the thriving market. The company’s dedication to excellence is reflected in its cutting-edge facilities and extraction processes, and Boston Hemp prides itself on delivering premium products to meet the growing demand from consumers seeking high-quality and natural alternatives in all 50 states. “We are thrilled to be recognized as the nation’s largest supplier of premium,…

Continue Reading

ThursdayApr 11, 2024 3:00 pm

NetworkNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Leveraging Strategic Integrations to Unlock Continued Opportunities

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process and freight logistics, continues to be a marketplace partner with Geotab, a prominent company in the technology and logistics industry. “Fr8Tech announced last September that it had integrated its Fr8App freight-matching platform with Geotab’s open application programming interface (‘API’). According to the company, this integration was intended not only to boost substantially real-time visibility and efficiency for carriers and shippers but also to ensure that clients enjoy added capabilities through the Fr8App platform. The integration exemplifies Fr8App’s continuous improvement and Fr8Tech’s investment…

Continue Reading

ThursdayApr 11, 2024 2:29 pm

NetworkNewsBreaks – Correlate Energy Corp. (CIPI) Enabling Businesses with Green Solutions

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is working with U.S. businesses and government programs to make solar power and other green energy solutions accessible to mid-tier entities that are often overlooked by large energy companies and consulting firms. “As Correlate works to build partners similarly inclined to find green solutions, the company has announced a partnership with Carbonsight (by Autocase) that is designed to assist corporate building portfolio managers as they try to improve their green footprints. Carbonsight is an online decarbonization planning tool that organizes data for potential…

Continue Reading

ThursdayApr 11, 2024 2:07 pm

NetworkNewsBreaks – Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) Files NI 43-101 Technical Report for Oko West Project

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) today announce the filing of the National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) entitled “NI 43-101 Technical Report, Oko West Gold Project, Cuyuni-Mazaruni Mining Districts, Guyana.” The report is dated April 11, 2024, with an effective date of February 26, 2024, to support scientific and technical information that relates to the Oko West Project and the updated Mineral Resource Estimate (“MRE”) published on Feb. 26, 2024. According to the announcement, the updated MRE showed a significant increase in both grades and contained gold within the overall MRE and also included…

Continue Reading